arrow
B

Beverley M. Shields

university of exeter medical school
H指数:71
被引数:3.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The DePICtion study: Implementing a diabetes classification tool in UK primary care—A qualitative study with primary care staff and patients

DePICtion研究:在英国初级保健中实施糖尿病分类工具——一项与初级保健工作人员和患者的定性研究

2026-10-250
OA
Trends in Second‐Line Initiations and Treatment Outcomes Across Age and Frailty Groups in People With Type 2 Diabetes: UK Population‐Based Study, 2019–2024

2型糖尿病患者中二线治疗启动趋势及不同年龄和虚弱程度人群的治疗结局: <scp>UK</scp> 基于人群的研究,2019–2024

2026-06-040
OA
Can 4 weeks of real-world active breaks improve glycaemic management in sedentary adults with type 1 diabetes? The EXTOD-Active randomised control trial protocol

4周的真实世界活动休息能改善久坐不动的1型糖尿病成人的血糖管理吗?EXTOD-主动随机对照试验方案

2025-04-050
OAAI
Treatment outcomes with oral anti-hyperglycaemic therapies in people with diabetes secondary to a pancreatic condition (type 3c diabetes): A population-based cohort study

胰腺疾病继发糖尿病 (3c型糖尿病) 患者口服抗高血糖治疗的疗效: 一项基于人群的队列研究

2025-01-060
OAAI
MODY Calculator and Clinical Features Routinely Used to Distinguish MODY From Type 2 Diabetes in Adults Perform Poorly for Youth Clinically Diagnosed With Type 2 Diabetes

MODY计算器和临床特征通常用于区分MODY和成人2型糖尿病,对于临床诊断为2型糖尿病的青年表现不佳

2024-11-180
OAAI
Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach

SGLT2抑制剂在英国70岁以上2型糖尿病患者中的安全性和有效性: 工具变量方法

2024-06-052
OAAI
Incretin hormone responses to carbohydrate and protein/fat are preserved in adults with sulfonylurea-treated KCNJ11 neonatal diabetes

在接受磺脲类药物治疗的KCNJ11新生儿糖尿病的成年人中,肠促胰岛素对碳水化合物和蛋白质/脂肪的反应得以保留

2023-08-210
OAAI